Showing results (591-600 of 612) with videos related to
Sort By:
Pageof 62
Nephron|January 1, 1994
Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trialP Herrmann, E Ritz, H Schmidt-Gayk, et al.European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetics of ramipril in hypertensive patients with renal insufficiencyH Schunkert, J Kindler, M Gassmann, et al.Nature Genetics|January 13, 1998
Association of a human G-protein beta3 subunit variant with hypertensionW Siffert, D Rosskopf, G Siffert, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitusM Zumbach, M Hofmann, V Borcea, et al.The New England Journal of Medicine|September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesE J Lewis, L G Hunsicker, W R Clarke, et al.Journal of Human Hypertension|December 15, 2010
Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)A Januszewicz, E Ritz, G Viberti, et al.American Journal of Nephrology|June 13, 2009
The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristicsH J Lambers Heerspink, R Agarwal, D W Coyne, et al.The American Journal of Physiology|December 22, 1999
Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic ratsC Tschöpe, A Reinecke, U Seidl, et al.Diabetologia|October 31, 2009
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyE Ritz, G C Viberti, L M Ruilope, et al.Kidney International|September 12, 1998
Smoking as a risk factor for end-stage renal failure in men with primary renal diseaseS R Orth, A Stöckmann, C Conradt, et al.Pageof 62